EVIDENCE ON HARM REDUCTION AND ADDICTION POLICY
Discussion on the use of harm reduction in policy development has been increasingly visible in past months, especially in the context of the Europe’s Beating Cancer Plan debate. Where some see clear benefits for public health, others mention the danger of disproportionate deregulation.
WHY IS HARM REDUCTION THE ONLY WAY?
17 February 2021, 13:00 – 14:30, online webinar
Discussion on the use of harm reduction in policy development has been increasingly visible in past months, especially in the context of the Europe’s Beating Cancer Plan debate. Where some see clear benefits for public health, others mention the danger of disproportionate deregulation. For what policies is harm reduction appropriate and where are its limits? These are some of the questions to be debated by Alexis Goosdeel, Director of EMCDDA and Jindřich Vobořil, Head of the Institute for Rational Addiction Policies (IRAP). IRAP is Central Europe’s frontrunning NGO with an outstanding track record in the field of addictions based in Brno, Czech Republic.
Programme of the webinar:
13:00 – 13:20 Jindřich Vobořil, Head of IRAP and former Czech National Anti-Drug Coordinator Harm reduction as a needed principle in health policy-making
13:20 – 13:40 Alexis Goosdeel, Director of the European Monitoring Centre for Drugs and Drug Addiction Risk reduction and EMCDDA
13:40 – 14:30 Q&A with the panelists
